2026, patient information sheet, attached document.[3] Therapeutic Goods Administration (TGA) 2025, ACM meeting statement, Meeting 53, 3 October 2025, TGA.[1] Diabetes Australia 2024, Wegovy to be available in Australia, Diabetes Australia.[4] Hormones Australia 2023, New diabetes drug Mounjaro approved by the TGA, Hormones Australia.[5] Pharmacy Daily 2022, Wegovy gets green light from TGA, Pharmacy Daily.[6] RACGP 2025, Wegovy approved for cutting cardiovascular disease risk, RACGP.[7] Semaglutide-use-and-NAION-risks-with-references.docx
GLP-1 agents slow gastric emptying, which may affect absorption of other medications
How does the Precision Peptide Genetic Test help with pregnancy planning
A Case of Hirata Syndrome in Pregnancy Induced by -Lipoic Acid: Diagnosis and Management
It is unclear whether hyperandrogenism is the result of hyperinsulinemia or vice versa [50]